« Previous
Next »
Experimental Hematology
Volume 35, Issue 3
, Pages 385-393
, March 2007
Bcl-2 and Bcl-XL are indispensable for the late phase of mast cell development from mouse embryonic stem cells
References
- . Ways of dying: multiple pathways to apoptosis. Genes Dev. 2003;17:2481–2495
- . Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci. 2001;26:61–66
- . Apoptosis signaling. Annu Rev Biochem. 2000;69:217–245
- . Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002;2:773–786
- . IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol. 1993;151:3775–3784
- . The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol. 1994;144:321–328
- Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood. 2005;106:1330–1336
- . Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med. 2001;194:1561–1569
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597–608
- . Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 1996;88:386–401
- Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2. Int Arch Allergy Immunol. 2002;129:228–236
- . Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol. 2001;21:171–174
- Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol. 2003;163:819–826
- . A role for Bax in the regulation of apoptosis in mouse mast cells. J Invest Dermatol. 2000;114:1205–1206
- . A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood. 2003;102:2506–2512
- . Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ. 2005;12:136–144
- Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 1995;267:1506–1510
- Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science. 1993;261:1584–1588
- . Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development. 1991;111:259–267
- . In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc Natl Acad Sci U S A. 2000;97:9186–9190
- . Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci U S A. 1994;91:3700–3704
- . Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int J Hematol. 2002;75:345–349
- . A novel function for transforming growth factor-beta1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1. Blood. 1999;93:3473–3486
- . Multiple gene duplication and expression of mouse bcl-2-related genes, A1. Int Immunol. 1998;10:631–637
- . Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection. Cell Death Differ. 2005;13:1213–1217
- . Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival. Clin Exp Allergy. 2003;33:1135–1140
- . Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. J Biol Chem. 1996;271:27500–27508
- Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J Exp Med. 2000;192:1093–1103
- . Mast cell growth, differentiation, and death. Clin Rev Allergy Immunol. 2002;22:107–118
- . Decreased production of mast cells in S1/S1d anemic mice. Blood. 1979;53:492–497
- . Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978;52:447–452
- Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature. 1998;392:90–93
- . Interleukin 3 perfusion in W/Wv mice allows the development of macroscopic hematopoietic spleen colonies and restores cutaneous mast cell number. J Exp Med. 1990;172:403–406
- . Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen. Blood. 2005;105:2059–2065
- Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes. J Leukoc Biol. 2003;74:923–931
- . Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med. 2000;192:1707–1718
- Stat5 expression is critical for mast cell development and survival. Blood. 2003;102:1290–1297
- . IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils. Allergy. 2006;61:1040–1046
- . Involvement of Bcl-2 family proteins in germ cell apoptosis during testicular development in the rat and pro-survival effect of stem cell factor on germ cells in vitro. Mol Cell Endocrinol. 2000;165:115–129
- . IgE-receptor activation of mast cells regulates phosphorylation and expression of forkhead and Bcl-2 family members. Scand J Immunol. 2006;63:1–6
- . The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr Biol. 1998;8:779–782
PII: S0301-472X(06)00704-1
doi: 10.1016/j.exphem.2006.11.008
© 2007 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 35, Issue 3
, Pages 385-393
, March 2007
